Value Microcaps Zip Code Changers

[Potse]

FZMD(.80)...CEO open-market purchases.....

As I mentioned in the above post, this should develop into a potentially very interesting low float situation following the reverse split and RM acquisition. Outstanding share count after the RM will be 4M shares. The float should be extremely tight for quite awhile, and momentum players will probably be able to move the stock with relative ease.

As far as I am aware, I believe this is the first company that Alan Meeker (Chairman of Fuse Medical) will have brought public. I think most of Meeker's wealth has been obtained through his oil/gas investments, but he has become somewhat "famous" in the last couple/few years for his involvement in cloning race/polo horses through his Crestview Genetics company.

FZMD has not yet updated its new website, issued any press release, or done anything IR-related since the reverse merger occurred.

But just very recently the email contact on FZMD's website was changed to what I think is Alan Meeker's email address. And Meeker has made some minor open-market purchases at prices above $1 within the last couple of weeks.

The last quarterly report contains some interesting statements/commentary in the liquidity section of the report. This language seems to suggest that FZMD is expecting a relatively significant positive financial change in its current/existing operating activities over the next few quarters.....

Commencing with the fourth quarter of 2014, we expect to ramp up our revenues derived from the sale of internal fixation products, which will increase the amount of gross profit from operations. Accordingly, we shall have increased spending on payroll expenses as we increase our professional staff in this effort. Based on the funds we had available on September 30, 2014, we believe that we have sufficient capital to fund our anticipated operating expenses for at least twelve months.

Despite the amount of funds that we raised from the issuance of promissory notes, the estimated costs of operations while we ramp up our revenues is substantially greater than the amount of funds we had available on September 30, 2014. Therefore, while we believe that our existing cash balances will be sufficient to fund our currently planned level of operations for at least twelve months, we will have to obtain additional funds in the future to complete our development plans. We intend to seek this additional funding through various financing sources, including possible sales of our securities. No assurance can be given that such financing will be available, or if available, at rates favorable to the Company or its stockholders. Management expects that the Company will attain positive cash flow in the quarter ending June 30, 2015.

http://www.sec.gov/Archives/edgar/data/319016/000147793214006531/fzmd_10q.htm

http://www.fusemedical.com/